Barbato, Angelo
D’Avanzo, Barbara
Corrao, Giovanni http://orcid.org/0000-0002-1034-8444
Di Fiandra, Teresa
Ferrara, Lucia
Gaddini, Andrea
Jarach, Carlotta Micaela
Monzio Compagnoni, Matteo http://orcid.org/0000-0002-2105-4572
Saponaro, Alessio
Scondotto, Salvatore
Tozzi, Valeria D
Lora, Antonio http://orcid.org/0000-0002-6806-5199
Funding for this research was provided by:
UniversitĂ degli Studi di Milano - Bicocca
Article History
Received: 1 September 2023
Accepted: 12 October 2023
First Online: 26 October 2023
Declarations
:
: Author #3 received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche. Author #12 was employed by ASST Lecco. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The Ethical Committee of the University of Milano-Bicocca evaluated the protocol (Protocol number 497, Year 2019) and established that the study (i) was exempt from patients informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes Issued by the Italian Privacy Authority on August 10, 2018; ExternalRef removed); (ii) provides sufficient guarantees of individual records anonymity; and (iii) was designed according to quality standards of good practice of observational research based on secondary data.
: Not applicable.
: Not applicable.